Phase I trial of the combination of perifosine and gemcitabine.

Trial Profile

Phase I trial of the combination of perifosine and gemcitabine.

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Jun 2015

At a glance

  • Drugs Gemcitabine (Primary) ; Perifosine (Primary)
  • Indications Cancer
  • Focus Adverse reactions
  • Sponsors AOI Pharmaceuticals; Keryx Biopharmaceuticals
  • Most Recent Events

    • 09 Aug 2012 Company added in association field as reported by ClinicalTrials.gov.
    • 25 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top